Program News
News and stories about members of the UNC Lineberger Breast Cancer Research Program
-
Hormone therapy or chemotherapy? A test developed by a UNC researcher can tell you
A cancer diagnostic test developed by a group of researchers, including Charles Perou, PhD, has been found to accurately predict whether patients with breast cancer actually need chemotherapy – or if hormone therapy alone can put them on a path towards remission.
-
UNC Center for Environmental Health and Susceptibility receives $7.7 million from NIEHS
This grant supports research and community engagement to improve environmental health and well-being for people in North Carolina and beyond, including understanding how environmental exposures contribute to cancer risk and identifying opportunities for prevention.
-
Rooted: Caterina Gallippi
Caterina Gallippi, PhD, is a biomedical engineer advancing ultrasound innovations to help clinicians detect and monitor disease in real time without radiation, supporting faster, more accessible care for cancer and other conditions.
-
UNC Lineberger members to present at American Society of Clinical Oncology Annual Meeting
UNC Lineberger members will share their latest research findings and clinical insights during the American Society of Clinical Oncology’s annual meeting in Chicago, taking place May 30 – June 3.
-
Perou named Honorary Doctor by Karolinska Institutet
UNC Lineberger’s Charles Perou, PhD, was awarded the title of Honorary Doctor by Karolinska Institutet in Sweden in recognition of his groundbreaking contributions to breast cancer research.
-
A new clinical trial for metastatic breast cancer opens
A new clinical trial that adjusts treatment as breast cancer evolves is now open and enrolling patients at UNC Lineberger Comprehensive Cancer Center.
-
UNC School of Medicine oncologist named recipient of Winn Clinical Investigator Leadership Award
Yara Abdou, MD, is among the third cohort of physician researchers to receive the Robert A. Winn Excellence in Clinical Trials: Clinical Investigator Leadership Award.
-
UNC Lineberger researchers among world’s most influential in Clarivate 2025 Highly Cited Researchers list
Eleven UNC Lineberger Comprehensive Cancer Center members were named as 2025 Highly Cited Researchers by Clarivate for publishing some of the most influential scientific papers during the past decade.
-
UNC Lineberger continues its national leadership in breast cancer research
UNC Lineberger researchers are leading next-generation clinical breast cancer trials as part of a national project using cutting-edge technologies to track tumor changes in real time.
-
Carey named a ‘Giant’ of breast cancer care
Lisa Carey, MD, ScM, FASCO, was honored by OncLive as one of its 2025 Giants of Cancer Care for her significant contributions advancing the treatment and study of breast cancer.
-
UNC Lineberger awarded up to $28M to develop an adaptive clinical trial for metastatic breast cancer
UNC Lineberger will lead the development of a next-generation clinical trial for metastatic breast cancer. The new trial design will adapt treatment plans in near real-time by analyzing changes in each patient’s cancer and matching it to the most promising therapy.
-
UNC Lineberger faculty and trainees present research, receive honors at cancer research meeting
UNC Lineberger faculty and trainees presented research findings and participated in panel discussions at the American Society of Clinical Oncology’s annual meeting in Chicago.
-
‘Breast cancer is a team sport’
Lisa Carey, MD, ScM, FASCO, talks about the importance of research, coordinated care and helping patients make informed choices.
-
UNC faculty and trainees to present at the world’s largest clinical cancer research meeting
UNC faculty and trainees will share their latest research findings and clinical insights during talks, poster presentations and panel discussions during the American Society of Clinical Oncology’s annual meeting in Chicago, taking place May 30 – June 3.
-
Trial and discovery
Carolina researchers are pushing the boundaries of medicine through clinical trials — driving innovation, uncovering new therapies, and shaping a future where science transforms lives.